Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Anthony Elias

Concepts (606)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Breast Neoplasms
104
2024
1870
6.690
 Why?
Antineoplastic Combined Chemotherapy Protocols
91
2024
1360
3.970
 Why?
Sarcoma
32
2022
137
3.520
 Why?
Receptors, Estrogen
22
2021
372
2.550
 Why?
Triple Negative Breast Neoplasms
13
2023
157
2.350
 Why?
Receptor, ErbB-2
21
2024
302
2.190
 Why?
Hematopoietic Stem Cell Transplantation
33
2011
524
1.960
 Why?
Soft Tissue Neoplasms
14
2022
90
1.750
 Why?
Carcinoma, Small Cell
17
2003
159
1.700
 Why?
Carcinoma, Ductal, Breast
7
2018
76
1.610
 Why?
Antineoplastic Agents
31
2023
1891
1.390
 Why?
Neoplasm Recurrence, Local
19
2022
862
1.340
 Why?
Neoadjuvant Therapy
15
2024
301
1.260
 Why?
Receptors, Progesterone
13
2020
319
1.140
 Why?
Biomarkers, Tumor
17
2022
1045
1.110
 Why?
Neoplasm Staging
32
2020
1177
1.080
 Why?
Lung Neoplasms
36
2003
2207
1.070
 Why?
Combined Modality Therapy
50
2021
1128
1.020
 Why?
Mastectomy
9
2018
99
1.020
 Why?
Paclitaxel
13
2024
192
0.950
 Why?
Bone Marrow Transplantation
26
1998
241
0.870
 Why?
Antineoplastic Agents, Alkylating
5
2018
68
0.810
 Why?
Receptors, Androgen
7
2018
132
0.790
 Why?
Female
158
2024
60086
0.780
 Why?
Doxorubicin
20
2020
290
0.750
 Why?
Antibodies, Monoclonal, Humanized
8
2022
665
0.750
 Why?
Antineoplastic Agents, Hormonal
10
2018
139
0.730
 Why?
Disease-Free Survival
23
2023
621
0.730
 Why?
Bone Neoplasms
6
2022
194
0.730
 Why?
Humans
210
2024
115908
0.730
 Why?
Maytansine
3
2021
13
0.710
 Why?
Liposarcoma
4
2023
26
0.710
 Why?
Middle Aged
104
2021
27084
0.700
 Why?
Chemotherapy, Adjuvant
23
2023
334
0.640
 Why?
Dioxoles
2
2015
9
0.610
 Why?
Tetrahydroisoquinolines
2
2015
8
0.610
 Why?
Adult
104
2021
30820
0.580
 Why?
Neoplasm Metastasis
21
2020
526
0.580
 Why?
Ifosfamide
19
1998
32
0.560
 Why?
Androgen Receptor Antagonists
6
2021
30
0.560
 Why?
Phenylthiohydantoin
5
2017
40
0.560
 Why?
Dasatinib
1
2016
45
0.550
 Why?
Neoplasms, Hormone-Dependent
3
2012
38
0.520
 Why?
Cyclophosphamide
29
2020
218
0.500
 Why?
Aged
59
2023
19299
0.490
 Why?
Estrogen Receptor alpha
5
2021
120
0.490
 Why?
Carboplatin
21
2016
139
0.480
 Why?
Granulocyte Colony-Stimulating Factor
11
2002
70
0.480
 Why?
Treatment Outcome
39
2022
9166
0.480
 Why?
Clinical Trials as Topic
19
2018
945
0.470
 Why?
Carcinoma, Non-Small-Cell Lung
16
1997
964
0.450
 Why?
Drug Administration Schedule
23
2018
724
0.450
 Why?
Estrogens
6
2018
316
0.450
 Why?
Neoplasms
19
2009
2112
0.430
 Why?
Dacarbazine
9
2018
100
0.420
 Why?
Trastuzumab
8
2024
89
0.420
 Why?
Tamoxifen
9
2018
192
0.400
 Why?
Pyrimidines
3
2020
376
0.390
 Why?
Survival Rate
18
2021
1653
0.380
 Why?
Survival Analysis
22
2010
1221
0.380
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2013
934
0.380
 Why?
Prognosis
20
2021
3342
0.370
 Why?
Neoplasms, Second Primary
3
2022
91
0.370
 Why?
Dose-Response Relationship, Drug
17
2017
1868
0.360
 Why?
Carcinoma, Intraductal, Noninfiltrating
3
2022
50
0.360
 Why?
Granulocyte-Macrophage Colony-Stimulating Factor
7
1999
139
0.350
 Why?
Drug Resistance, Neoplasm
7
2017
638
0.350
 Why?
Taxoids
7
2023
94
0.350
 Why?
Breast Neoplasms, Male
3
2018
28
0.340
 Why?
Gene Expression Regulation, Neoplastic
11
2018
1143
0.340
 Why?
Neoplastic Cells, Circulating
2
2020
59
0.320
 Why?
Mesna
12
1998
17
0.310
 Why?
Remission Induction
15
2002
240
0.310
 Why?
Sarcoma, Ewing
3
2022
62
0.300
 Why?
Cisplatin
14
2000
263
0.290
 Why?
Leiomyosarcoma
2
2018
24
0.290
 Why?
Sternum
1
2006
17
0.280
 Why?
Immunohistochemistry
5
2016
1643
0.270
 Why?
Mastectomy, Segmental
2
2009
76
0.270
 Why?
Carcinoma, Ductal
1
2005
11
0.250
 Why?
Protein Kinase Inhibitors
4
2019
789
0.250
 Why?
Ovarian Neoplasms
3
2022
407
0.250
 Why?
Cell Adhesion Molecules
2
2021
169
0.250
 Why?
Lymph Nodes
1
2007
422
0.250
 Why?
Carcinoma
2
2008
200
0.240
 Why?
Risk Reduction Behavior
2
2016
196
0.240
 Why?
Survivors
3
2016
405
0.230
 Why?
Drug Evaluation
19
1998
79
0.230
 Why?
Weight Loss
4
2016
632
0.230
 Why?
Deoxycytidine
4
2020
140
0.230
 Why?
Adjuvants, Immunologic
3
2022
205
0.230
 Why?
Hodgkin Disease
4
2016
118
0.230
 Why?
Antibodies, Monoclonal
8
2021
1262
0.230
 Why?
Ribonuclease III
2
2016
33
0.230
 Why?
Behavior Therapy
2
2016
227
0.220
 Why?
Thiotepa
13
2002
19
0.220
 Why?
DEAD-box RNA Helicases
2
2016
55
0.220
 Why?
Obesity
4
2018
2530
0.220
 Why?
Alkylating Agents
3
2000
26
0.220
 Why?
Triazoles
2
2022
131
0.220
 Why?
Gene Expression Profiling
6
2017
1548
0.220
 Why?
Overweight
3
2016
468
0.220
 Why?
Aged, 80 and over
13
2021
6438
0.210
 Why?
Transplantation, Autologous
17
2001
176
0.210
 Why?
Disease Management
5
2020
562
0.210
 Why?
Referral and Consultation
1
2007
647
0.210
 Why?
Male
61
2022
56128
0.210
 Why?
Salvage Therapy
6
2010
128
0.210
 Why?
Circulating Tumor DNA
1
2022
21
0.210
 Why?
Hydrazines
1
2022
28
0.200
 Why?
Peripheral Blood Stem Cell Transplantation
1
2002
19
0.200
 Why?
Melphalan
9
2002
29
0.200
 Why?
Carcinoma in Situ
2
2012
44
0.200
 Why?
Etoposide
10
2001
149
0.200
 Why?
Tumor Cells, Cultured
9
2020
850
0.200
 Why?
Sarcoma, Synovial
1
2021
10
0.200
 Why?
Hematologic Diseases
6
2008
57
0.200
 Why?
Liposarcoma, Myxoid
1
2021
6
0.200
 Why?
Aromatase Inhibitors
4
2021
49
0.190
 Why?
Recombinant Fusion Proteins
1
2024
616
0.190
 Why?
Endpoint Determination
1
2021
69
0.190
 Why?
Time Factors
12
2020
6186
0.180
 Why?
Sentinel Lymph Node Biopsy
3
2017
97
0.180
 Why?
Hematopoietic Stem Cells
5
1996
356
0.180
 Why?
Cancer Care Facilities
1
2020
30
0.180
 Why?
Indazoles
1
2020
58
0.180
 Why?
Diet
3
2018
1075
0.180
 Why?
Leukocytes, Mononuclear
3
2020
503
0.180
 Why?
Antigens, Neoplasm
4
2021
224
0.180
 Why?
Cell Separation
3
2017
293
0.180
 Why?
Diphosphonates
1
2020
51
0.180
 Why?
Cell Line, Tumor
9
2017
2749
0.180
 Why?
Pyrroles
2
2013
185
0.170
 Why?
Bone Marrow
8
2000
248
0.170
 Why?
Medical Oncology
4
2023
230
0.170
 Why?
Proportional Hazards Models
6
2020
1088
0.170
 Why?
Epithelial-Mesenchymal Transition
1
2020
168
0.160
 Why?
MCF-7 Cells
5
2017
106
0.160
 Why?
Fluorouracil
7
2013
151
0.160
 Why?
Indoles
2
2013
309
0.160
 Why?
Nitriles
5
2017
152
0.160
 Why?
Benzamides
5
2017
169
0.160
 Why?
Bayes Theorem
4
2024
336
0.160
 Why?
Research Design
3
2021
947
0.160
 Why?
Programmed Cell Death 1 Receptor
1
2020
193
0.160
 Why?
Cyclin-Dependent Kinase 4
1
2018
33
0.150
 Why?
Cell Cycle
1
2021
546
0.150
 Why?
Receptor, Fibroblast Growth Factor, Type 1
1
2018
49
0.150
 Why?
Cyclin-Dependent Kinase 6
1
2018
37
0.150
 Why?
Kaplan-Meier Estimate
6
2018
819
0.150
 Why?
Fibromatosis, Aggressive
1
2017
18
0.150
 Why?
Immunotherapy
2
2018
480
0.150
 Why?
Tetrahydronaphthalenes
1
2017
31
0.150
 Why?
Microbubbles
1
2017
40
0.150
 Why?
Vaccines
1
2022
376
0.150
 Why?
Lymph Node Excision
3
2015
140
0.150
 Why?
Valine
1
2017
74
0.150
 Why?
Sulfonamides
1
2020
447
0.150
 Why?
Amyloid Precursor Protein Secretases
1
2017
72
0.140
 Why?
Axilla
3
2017
38
0.140
 Why?
Cancer-Associated Fibroblasts
1
2016
10
0.140
 Why?
Androgen Antagonists
2
2015
69
0.140
 Why?
Infusions, Intravenous
9
2020
374
0.140
 Why?
Gonadal Steroid Hormones
1
2018
124
0.140
 Why?
Neoplasms, Radiation-Induced
1
2016
65
0.140
 Why?
Neoplasms, Germ Cell and Embryonal
2
1995
60
0.140
 Why?
Lymphatic Metastasis
3
2017
275
0.140
 Why?
Hematopoietic Cell Growth Factors
2
1995
4
0.140
 Why?
Ultrasonography, Mammary
1
2016
11
0.140
 Why?
Tumor Suppressor Protein p53
2
2023
448
0.140
 Why?
Thiazoles
1
2016
112
0.130
 Why?
Neoplasm Invasiveness
3
2016
445
0.130
 Why?
Antibody Specificity
1
2016
180
0.130
 Why?
Neoplastic Stem Cells
2
2017
330
0.130
 Why?
Maximum Tolerated Dose
1
2016
182
0.130
 Why?
Antibiotics, Antineoplastic
1
2016
114
0.130
 Why?
Mammography
1
2016
106
0.130
 Why?
Quinolines
1
2016
129
0.130
 Why?
Benzimidazoles
1
2016
137
0.130
 Why?
Exercise
2
2015
1611
0.130
 Why?
Pyrazoles
1
2018
362
0.130
 Why?
Disease Progression
7
2018
2424
0.130
 Why?
Recurrence
5
2020
949
0.130
 Why?
Drug Therapy, Combination
4
2014
961
0.120
 Why?
Animals
16
2021
32123
0.120
 Why?
Homeodomain Proteins
2
2018
465
0.120
 Why?
Radiotherapy, Adjuvant
5
2016
182
0.120
 Why?
Administration, Oral
4
2020
731
0.120
 Why?
TOR Serine-Threonine Kinases
1
2017
361
0.120
 Why?
Mice
12
2021
15075
0.120
 Why?
Societies, Medical
1
2018
690
0.120
 Why?
Poly(ADP-ribose) Polymerase Inhibitors
3
2022
67
0.120
 Why?
Brain Edema
1
2014
59
0.120
 Why?
Epigenesis, Genetic
2
2018
531
0.120
 Why?
Antibodies
1
2016
374
0.120
 Why?
Radiotherapy Dosage
3
1999
246
0.120
 Why?
Comorbidity
5
2017
1476
0.110
 Why?
Vascular Neoplasms
1
2013
16
0.110
 Why?
Testicular Neoplasms
1
1995
95
0.110
 Why?
Radiotherapy
3
2015
177
0.110
 Why?
CA-125 Antigen
1
2013
13
0.110
 Why?
Keratins
2
2017
176
0.110
 Why?
Cellular Reprogramming
1
2014
84
0.110
 Why?
Bridged-Ring Compounds
3
2020
9
0.110
 Why?
Cell Proliferation
6
2017
2196
0.110
 Why?
Mercaptoethanol
2
1990
11
0.110
 Why?
Patient Selection
4
2016
656
0.110
 Why?
Brain Neoplasms
5
2014
979
0.110
 Why?
Apoptosis
6
2023
2377
0.110
 Why?
Retrospective Studies
12
2023
12616
0.110
 Why?
Adenocarcinoma
5
2015
797
0.110
 Why?
Chromatin
1
2016
427
0.110
 Why?
Bone Marrow Cells
4
2000
272
0.110
 Why?
Young Adult
9
2021
10518
0.110
 Why?
Gallium Radioisotopes
1
1992
19
0.110
 Why?
Liver Neoplasms
3
2015
521
0.100
 Why?
Carmustine
10
2001
47
0.100
 Why?
Protein-Tyrosine Kinases
2
2022
394
0.100
 Why?
Lymphoma, Non-Hodgkin
3
2001
72
0.100
 Why?
Anthracyclines
3
2023
41
0.100
 Why?
Tumor Microenvironment
3
2021
424
0.100
 Why?
Methotrexate
4
2002
228
0.100
 Why?
Weight Reduction Programs
1
2012
91
0.100
 Why?
Neoplasm, Residual
2
2022
105
0.100
 Why?
Radiosurgery
1
2014
298
0.100
 Why?
Mutation
3
2020
3371
0.100
 Why?
Aorta
1
2013
354
0.090
 Why?
RNA, Catalytic
1
2012
182
0.090
 Why?
Neoplasm Grading
3
2017
244
0.090
 Why?
Neutropenia
5
2013
127
0.090
 Why?
Carcinoma, Lobular
1
2011
44
0.090
 Why?
Multivariate Analysis
4
2013
1444
0.090
 Why?
Leukapheresis
4
2001
25
0.090
 Why?
Adolescent
21
2018
17955
0.090
 Why?
Molecular Targeted Therapy
3
2018
348
0.090
 Why?
Keratin-5
1
2010
46
0.090
 Why?
Angiogenesis Inhibitors
1
2012
216
0.090
 Why?
Electrophoresis, Gel, Two-Dimensional
1
2010
100
0.090
 Why?
Peptide Mapping
1
2010
59
0.090
 Why?
Databases, Protein
1
2010
58
0.090
 Why?
Urinary Tract
1
1990
37
0.090
 Why?
Postmenopause
2
2017
301
0.080
 Why?
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
1
2010
139
0.080
 Why?
CD146 Antigen
2
2021
38
0.080
 Why?
Benzenesulfonates
1
2009
21
0.080
 Why?
United States
9
2023
12338
0.080
 Why?
BRCA2 Protein
1
2009
42
0.080
 Why?
Health Facilities
1
2009
70
0.080
 Why?
Observer Variation
1
2010
299
0.080
 Why?
Pregnancy Complications, Neoplastic
1
2009
50
0.080
 Why?
Thrombophilia
1
2009
67
0.080
 Why?
Patient Care
1
2009
103
0.080
 Why?
Follow-Up Studies
4
2021
4446
0.080
 Why?
Biopsy
2
2018
1056
0.080
 Why?
Randomized Controlled Trials as Topic
6
2000
1216
0.080
 Why?
Xenograft Model Antitumor Assays
3
2017
703
0.080
 Why?
Mice, Nude
3
2017
639
0.080
 Why?
Fatigue
3
2018
295
0.080
 Why?
Perimenopause
1
2008
59
0.080
 Why?
Bone Marrow Diseases
4
2000
18
0.070
 Why?
In Situ Hybridization
2
2010
298
0.070
 Why?
In Situ Hybridization, Fluorescence
1
2008
310
0.070
 Why?
Quality of Life
2
2015
2392
0.070
 Why?
Risk Assessment
2
2020
3004
0.070
 Why?
Reproducibility of Results
2
2016
2814
0.070
 Why?
Blotting, Western
1
2010
1153
0.070
 Why?
Pneumonectomy
3
1997
126
0.070
 Why?
Sputum
1
1988
291
0.070
 Why?
Clinical Decision-Making
2
2020
275
0.070
 Why?
Pyridines
1
2009
425
0.070
 Why?
Neoplasm Proteins
2
2007
388
0.060
 Why?
Hepatic Veno-Occlusive Disease
2
1998
10
0.060
 Why?
Life Tables
2
2002
17
0.060
 Why?
Risk Factors
6
2020
8714
0.060
 Why?
Anilides
2
2016
67
0.060
 Why?
Predictive Value of Tests
2
2016
1817
0.060
 Why?
Positron-Emission Tomography
1
2006
290
0.060
 Why?
Magnetic Resonance Imaging
1
2016
3087
0.060
 Why?
Enzyme Inhibitors
1
2008
758
0.060
 Why?
MicroRNAs
1
2010
610
0.060
 Why?
Mammaplasty
2
2016
68
0.060
 Why?
Receptor, TIE-2
1
2024
12
0.060
 Why?
Genes, Neoplasm
1
2004
21
0.060
 Why?
Signal Transduction
5
2018
4526
0.060
 Why?
Ricin
2
1997
8
0.060
 Why?
Forecasting
3
2000
332
0.060
 Why?
Patient Care Planning
1
2005
142
0.060
 Why?
Oligonucleotide Array Sequence Analysis
3
2012
754
0.060
 Why?
Thrombocytopenia
3
2013
175
0.060
 Why?
Proteomics
1
2010
855
0.060
 Why?
Transcriptome
2
2023
742
0.060
 Why?
Activating Transcription Factor 4
1
2023
18
0.060
 Why?
Up-Regulation
2
2017
824
0.060
 Why?
Proteasome Inhibitors
1
2023
40
0.060
 Why?
Proto-Oncogene Proteins c-mdm2
1
2023
57
0.050
 Why?
G(M2) Ganglioside
1
2022
1
0.050
 Why?
Cyclin E
1
2022
21
0.050
 Why?
Injection Site Reaction
1
2022
3
0.050
 Why?
Clinical Trials, Phase III as Topic
2
2000
84
0.050
 Why?
Proteasome Endopeptidase Complex
1
2023
136
0.050
 Why?
Oncogene Proteins
1
2022
53
0.050
 Why?
Clinical Trials, Phase I as Topic
2
2020
47
0.050
 Why?
Ribose
1
2022
17
0.050
 Why?
Luminescent Measurements
1
2003
74
0.050
 Why?
Carbolines
1
2022
29
0.050
 Why?
Heterocyclic Compounds, 4 or More Rings
1
2022
16
0.050
 Why?
Blood Transfusion, Autologous
2
1993
19
0.050
 Why?
Tomography, X-Ray Computed
2
2015
2409
0.050
 Why?
Adenosine Diphosphate
1
2022
81
0.050
 Why?
Class I Phosphatidylinositol 3-Kinases
1
2022
76
0.050
 Why?
Oncogenes
1
2022
104
0.050
 Why?
Actuarial Analysis
2
1993
21
0.050
 Why?
Colony-Forming Units Assay
4
1996
92
0.050
 Why?
Cell Division
2
2001
760
0.050
 Why?
Gene Expression
2
2020
1442
0.050
 Why?
Longitudinal Studies
2
2012
2437
0.050
 Why?
Age Factors
3
2018
2912
0.050
 Why?
Phthalazines
1
2021
39
0.050
 Why?
Clodronic Acid
1
2020
8
0.050
 Why?
Estradiol
2
2016
453
0.050
 Why?
Transplantation Immunology
1
2000
31
0.050
 Why?
Progesterone
1
2002
232
0.040
 Why?
Ligands
1
2022
568
0.040
 Why?
Phosphatidylinositol 3-Kinases
1
2022
332
0.040
 Why?
Topoisomerase I Inhibitors
1
1999
16
0.040
 Why?
Thoracotomy
2
1997
67
0.040
 Why?
Leucovorin
2
1997
42
0.040
 Why?
Polymerase Chain Reaction
1
2003
1001
0.040
 Why?
Bone Density Conservation Agents
1
2020
62
0.040
 Why?
Prospective Studies
4
2022
6267
0.040
 Why?
Hematopoietic Stem Cell Mobilization
1
1999
20
0.040
 Why?
Dendritic Cells
2
2000
436
0.040
 Why?
Mechlorethamine
1
2000
64
0.040
 Why?
Myelodysplastic Syndromes
1
2001
118
0.040
 Why?
Drug Resistance
1
1999
162
0.040
 Why?
Cross-Over Studies
1
2020
437
0.040
 Why?
Neoplasms, Experimental
1
2000
153
0.040
 Why?
Heterocyclic Compounds, 3-Ring
1
2019
29
0.040
 Why?
Piperazines
1
2021
313
0.040
 Why?
Cell Cycle Proteins
1
2022
555
0.040
 Why?
Cluster Analysis
2
2012
466
0.040
 Why?
Receptors, Steroid
1
2019
52
0.040
 Why?
Polydeoxyribonucleotides
1
1998
12
0.040
 Why?
Colony-Stimulating Factors
2
1988
32
0.040
 Why?
Leukemia
1
2001
207
0.040
 Why?
Etanidazole
1
1998
1
0.040
 Why?
Enterocolitis, Pseudomembranous
1
1998
25
0.040
 Why?
Loss of Function Mutation
1
2018
39
0.040
 Why?
Nervous System
2
1997
63
0.040
 Why?
Child
7
2022
18555
0.040
 Why?
Granulocytes
3
1995
78
0.040
 Why?
Expectorants
1
1998
24
0.040
 Why?
Aurora Kinase A
1
2018
51
0.040
 Why?
Growth Substances
2
1988
136
0.040
 Why?
Statistics, Nonparametric
1
1999
390
0.040
 Why?
Disease Susceptibility
1
2020
321
0.040
 Why?
Nausea
1
2018
103
0.040
 Why?
Retreatment
1
2018
70
0.040
 Why?
Mediastinum
1
1998
21
0.040
 Why?
Administration, Intravenous
1
2018
126
0.040
 Why?
Epithelial Cell Adhesion Molecule
1
2017
10
0.040
 Why?
Medicare
1
2023
666
0.040
 Why?
Extremities
2
1989
113
0.040
 Why?
Breast
1
2018
139
0.040
 Why?
Double-Blind Method
1
2022
1665
0.040
 Why?
SEER Program
1
2018
193
0.040
 Why?
Watchful Waiting
1
2018
57
0.040
 Why?
Cohort Studies
4
2001
4960
0.040
 Why?
Diarrhea
1
2018
173
0.040
 Why?
Cell Hypoxia
1
1998
220
0.040
 Why?
Thorax
1
1997
41
0.040
 Why?
Everolimus
1
2017
63
0.040
 Why?
Random Allocation
2
1988
338
0.040
 Why?
Phosphoramide Mustards
1
2016
1
0.040
 Why?
Immunotoxins
1
1997
33
0.040
 Why?
Heterografts
1
2017
119
0.040
 Why?
Proto-Oncogene Proteins c-akt
1
2019
399
0.030
 Why?
Cyclohexanes
1
2016
22
0.030
 Why?
Lymphoma, Large B-Cell, Diffuse
1
1998
93
0.030
 Why?
Cytochrome P-450 CYP3A
1
2017
62
0.030
 Why?
Cell Survival
1
2000
1026
0.030
 Why?
Carcinogenesis
1
2018
177
0.030
 Why?
Placebos
1
2016
198
0.030
 Why?
Gene Knockdown Techniques
1
2017
304
0.030
 Why?
Antineoplastic Agents, Immunological
1
2018
153
0.030
 Why?
Fibrinolytic Agents
1
1998
233
0.030
 Why?
Injections, Intravenous
2
1993
204
0.030
 Why?
Blood Specimen Collection
1
1995
32
0.030
 Why?
Fertility Preservation
1
2016
47
0.030
 Why?
Kidney
2
1995
1208
0.030
 Why?
Mortality
1
1997
293
0.030
 Why?
Organoplatinum Compounds
3
1990
40
0.030
 Why?
Genetic Therapy
1
1997
267
0.030
 Why?
Antidotes
1
1997
135
0.030
 Why?
Transcriptional Activation
1
2017
341
0.030
 Why?
Blood Component Transfusion
2
1994
76
0.030
 Why?
Vincristine
1
1995
96
0.030
 Why?
Digestive System
1
1995
27
0.030
 Why?
Pulmonary Fibrosis
3
1993
331
0.030
 Why?
Weight Gain
1
2018
455
0.030
 Why?
Fertility
1
2016
131
0.030
 Why?
Interleukin-3
1
1994
23
0.030
 Why?
Hormones
1
2015
132
0.030
 Why?
Adipose Tissue
1
2018
553
0.030
 Why?
Bacterial Infections
1
1996
222
0.030
 Why?
Odds Ratio
1
2017
969
0.030
 Why?
Drug-Related Side Effects and Adverse Reactions
1
2017
242
0.030
 Why?
Tosyl Compounds
1
2014
14
0.030
 Why?
Drug Discovery
1
2015
124
0.030
 Why?
HEK293 Cells
1
2016
604
0.030
 Why?
Hand-Foot Syndrome
1
2013
2
0.030
 Why?
Alternative Splicing
1
2015
186
0.030
 Why?
Protein Transport
1
2015
400
0.030
 Why?
Erythropoietin
1
1994
72
0.030
 Why?
Capecitabine
1
2013
46
0.030
 Why?
Necrosis
1
2014
211
0.030
 Why?
Cell Nucleus
1
2016
554
0.030
 Why?
Transplantation, Heterologous
1
2014
188
0.030
 Why?
Camptothecin
1
1994
97
0.030
 Why?
Neoplasm Transplantation
1
2014
235
0.030
 Why?
Gene Silencing
1
2014
176
0.030
 Why?
Binding Sites
1
2016
1183
0.030
 Why?
Child, Preschool
5
2013
9175
0.030
 Why?
Nutritional Status
1
2015
287
0.030
 Why?
Blood Cells
1
1993
39
0.030
 Why?
Sensitivity and Specificity
2
2000
1728
0.030
 Why?
Energy Intake
1
2015
413
0.030
 Why?
Anemia
1
1994
144
0.030
 Why?
Recombinant Proteins
5
1997
1243
0.030
 Why?
Feasibility Studies
4
1998
750
0.030
 Why?
CD24 Antigen
1
2012
20
0.030
 Why?
Radionuclide Imaging
1
1992
121
0.030
 Why?
Counseling
1
2015
346
0.030
 Why?
Diet, Reducing
1
2012
79
0.030
 Why?
Models, Biological
1
1999
1647
0.030
 Why?
Psychotherapy, Group
1
2012
61
0.030
 Why?
Hyaluronan Receptors
1
2012
91
0.030
 Why?
Antigens, CD34
3
1996
97
0.030
 Why?
Leukocyte Count
4
1996
295
0.020
 Why?
Vascular Endothelial Growth Factor Receptor-1
1
2012
68
0.020
 Why?
Mice, SCID
1
2012
321
0.020
 Why?
Disease Models, Animal
1
2021
3582
0.020
 Why?
Tumor Burden
1
2012
261
0.020
 Why?
Logistic Models
1
2016
1865
0.020
 Why?
Fluorescent Antibody Technique
2
1990
399
0.020
 Why?
Colorado
1
2020
4122
0.020
 Why?
Internship and Residency
1
1980
949
0.020
 Why?
Gene Regulatory Networks
1
2012
233
0.020
 Why?
Biopsy, Needle
1
2011
183
0.020
 Why?
Mice, Inbred NOD
1
2012
562
0.020
 Why?
Blast Crisis
1
1990
19
0.020
 Why?
Chromosomes, Human, Pair 9
1
1990
43
0.020
 Why?
Pemetrexed
1
2010
27
0.020
 Why?
Graft Survival
1
1993
481
0.020
 Why?
Health Status
1
2015
733
0.020
 Why?
Chromosomes, Human, Pair 22
1
1990
39
0.020
 Why?
Hypertension
1
2018
1063
0.020
 Why?
Cytokines
1
1998
1857
0.020
 Why?
Kidney Diseases
2
1991
355
0.020
 Why?
Immunoblotting
1
2010
283
0.020
 Why?
Glutamates
1
2010
59
0.020
 Why?
Magnetics
1
1990
38
0.020
 Why?
Antibodies, Anti-Idiotypic
1
1990
54
0.020
 Why?
Urologic Diseases
1
1990
36
0.020
 Why?
Guanine
1
2010
76
0.020
 Why?
Cell Movement
1
2014
868
0.020
 Why?
Chromosome Aberrations
1
1990
136
0.020
 Why?
DNA Methylation
1
2014
498
0.020
 Why?
Health Behavior
1
2015
707
0.020
 Why?
Real-Time Polymerase Chain Reaction
1
2010
319
0.020
 Why?
Promoter Regions, Genetic
1
2014
1129
0.020
 Why?
Microspheres
1
1990
123
0.020
 Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
1990
93
0.020
 Why?
Lymphoma
1
1990
177
0.020
 Why?
Blood
1
1990
97
0.020
 Why?
Clone Cells
1
1990
247
0.020
 Why?
Pregnancy Trimester, Second
1
2009
66
0.020
 Why?
Spinal Cord Neoplasms
1
1989
40
0.020
 Why?
Central Nervous System Diseases
1
1990
62
0.020
 Why?
Macrophages
2
1995
1281
0.020
 Why?
Creatinine
1
1991
431
0.020
 Why?
Hematuria
1
1989
7
0.020
 Why?
Vinblastine
2
2001
61
0.020
 Why?
Histones
1
2014
539
0.020
 Why?
Immunophenotyping
2
2000
273
0.020
 Why?
Exercise Therapy
1
2012
353
0.020
 Why?
Niacinamide
1
2009
65
0.020
 Why?
False Negative Reactions
1
1988
52
0.020
 Why?
Pregnancy Trimester, First
1
2009
129
0.020
 Why?
Leukopenia
1
1988
27
0.020
 Why?
Phenylurea Compounds
1
2009
83
0.020
 Why?
Apoptosis Regulatory Proteins
1
2009
175
0.020
 Why?
False Positive Reactions
1
1988
111
0.020
 Why?
Transfection
1
2010
866
0.020
 Why?
Electrophoresis
1
1988
25
0.020
 Why?
Hospitals, Veterans
1
2009
245
0.020
 Why?
Drug Interactions
1
1990
347
0.020
 Why?
Perilipin-1
1
2008
16
0.020
 Why?
Estrogen Receptor Modulators
1
2008
17
0.020
 Why?
Staining and Labeling
1
1988
139
0.020
 Why?
Vimentin
1
1988
58
0.020
 Why?
S100 Proteins
1
2008
39
0.020
 Why?
Nervous System Diseases
1
1991
253
0.020
 Why?
Community Health Services
1
2009
212
0.020
 Why?
Biomarkers
1
2018
3474
0.020
 Why?
Central Nervous System
1
1990
239
0.020
 Why?
Androstadienes
1
2008
97
0.020
 Why?
Genetic Predisposition to Disease
1
2016
2209
0.020
 Why?
Sarcoma, Kaposi
1
1988
69
0.020
 Why?
Health Knowledge, Attitudes, Practice
1
2015
1193
0.020
 Why?
Lung Diseases
2
1992
710
0.020
 Why?
Bone Marrow Purging
2
1996
3
0.020
 Why?
Academic Medical Centers
1
2009
415
0.020
 Why?
Clinical Trials, Phase II as Topic
2
2000
58
0.020
 Why?
Heart Diseases
1
1990
337
0.020
 Why?
Risk
2
2000
830
0.020
 Why?
Gastrointestinal Diseases
1
2008
184
0.020
 Why?
Stem Cell Transplantation
1
2007
151
0.020
 Why?
Phosphoproteins
1
2008
302
0.020
 Why?
Immunoglobulin G
1
1990
782
0.020
 Why?
Bevacizumab
1
2006
118
0.020
 Why?
Body Mass Index
1
2012
1982
0.020
 Why?
Quality of Health Care
1
2009
578
0.020
 Why?
Melanoma
2
1988
649
0.020
 Why?
Carrier Proteins
1
2008
703
0.010
 Why?
Brain
1
2014
2382
0.010
 Why?
Phenotype
1
2010
2861
0.010
 Why?
Cells, Cultured
1
1990
3916
0.010
 Why?
Carcinoma, Lewis Lung
1
2001
13
0.010
 Why?
Hemorrhage
2
1998
616
0.010
 Why?
Drug Synergism
1
2001
316
0.010
 Why?
Phytohemagglutinins
1
2000
27
0.010
 Why?
CD4-CD8 Ratio
1
2000
19
0.010
 Why?
Lymphocyte Culture Test, Mixed
1
2000
43
0.010
 Why?
Hypersensitivity, Delayed
1
2000
52
0.010
 Why?
Microcomputers
1
2000
14
0.010
 Why?
Louisiana
1
2000
24
0.010
 Why?
France
1
2000
34
0.010
 Why?
Philadelphia
1
2000
46
0.010
 Why?
Skin Tests
1
2000
137
0.010
 Why?
Immunoglobulins
1
2000
148
0.010
 Why?
Automation
1
2000
73
0.010
 Why?
Immunity
1
2000
124
0.010
 Why?
Lung
1
1992
3685
0.010
 Why?
Personnel Selection
1
1980
67
0.010
 Why?
Heart Failure
1
1992
1959
0.010
 Why?
Marriage
1
1980
108
0.010
 Why?
Lipopolysaccharide Receptors
1
1999
85
0.010
 Why?
Multicenter Studies as Topic
1
2000
249
0.010
 Why?
Pilot Projects
2
1994
1374
0.010
 Why?
Thalassemia
1
1998
7
0.010
 Why?
Interleukin-4
1
1999
212
0.010
 Why?
Infant, Newborn
1
2009
5089
0.010
 Why?
Receptors, Purinergic P1
1
1998
23
0.010
 Why?
Reference Values
1
2000
745
0.010
 Why?
Bilirubin
1
1998
91
0.010
 Why?
Microscopy, Fluorescence
1
2000
403
0.010
 Why?
Acute Disease
1
2001
917
0.010
 Why?
Multiple Organ Failure
1
1998
144
0.010
 Why?
Pregnancy
1
2009
5556
0.010
 Why?
Killer Cells, Natural
1
2000
379
0.010
 Why?
Filgrastim
1
1997
10
0.010
 Why?
Heparin
1
1998
226
0.010
 Why?
Adenoviruses, Human
1
1996
24
0.010
 Why?
Lymphoma, B-Cell
1
1998
85
0.010
 Why?
Lymphocyte Activation
1
2000
1056
0.010
 Why?
Freezing
1
1996
85
0.010
 Why?
Tissue Plasminogen Activator
1
1998
228
0.010
 Why?
Lymphocyte Depletion
1
1996
115
0.010
 Why?
Genes, Reporter
1
1996
260
0.010
 Why?
Immunoconjugates
1
1997
87
0.010
 Why?
Drug Tolerance
1
1995
79
0.010
 Why?
Treatment Failure
1
1996
333
0.010
 Why?
Incidence
1
2001
2333
0.010
 Why?
Reticulocyte Count
1
1994
5
0.010
 Why?
Kidney Function Tests
1
1995
141
0.010
 Why?
Antigens, CD
1
1996
443
0.010
 Why?
Topotecan
1
1994
14
0.010
 Why?
Glioblastoma
1
1996
251
0.010
 Why?
Urinary Bladder Diseases
1
1993
19
0.010
 Why?
Flow Cytometry
1
1996
1059
0.010
 Why?
Chromatography, High Pressure Liquid
1
1995
477
0.010
 Why?
Heart
1
1997
612
0.010
 Why?
Boston
1
1993
76
0.010
 Why?
Iron
1
1994
235
0.010
 Why?
Palliative Care
1
1998
643
0.010
 Why?
Cell Line
1
1996
2655
0.010
 Why?
Immunologic Factors
1
1993
219
0.010
 Why?
Cystitis
1
1990
20
0.010
 Why?
Prostatic Neoplasms
1
1996
927
0.010
 Why?
Introns
1
1990
228
0.010
 Why?
Metabolic Clearance Rate
1
1989
108
0.010
 Why?
Platinum
1
1989
40
0.010
 Why?
Drug Combinations
1
1990
288
0.010
 Why?
Brain Diseases
1
1990
127
0.010
 Why?
Bone Marrow Examination
1
1988
7
0.000
 Why?
Platelet Count
1
1988
83
0.000
 Why?
Erythrocyte Count
1
1988
19
0.000
 Why?
Methods
1
1988
59
0.000
 Why?
Erythroblasts
1
1988
12
0.000
 Why?
Pelvic Neoplasms
1
1988
19
0.000
 Why?
Acute Kidney Injury
1
1995
647
0.000
 Why?
DNA Damage
1
1990
356
0.000
 Why?
Pneumonia
1
1992
576
0.000
 Why?
Fever
1
1988
280
0.000
 Why?
Statistics as Topic
1
1987
299
0.000
 Why?
Elias's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (606) concept(s)
_
Co-Authors Expand Description
See all (51) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)